AS
Ashish Shrikisan Sharma
About Ashish Shrikisan Sharma
Data last updated:
Ashish Shrikisan Sharma was a Director at Shri Sai Cottex Private Limited (2012–2017), Director at Kasa Electric Components Private Limited (1996–2019) and Designated Partner at Ganpati Constro Projects Limited Liability Partnership (from 2010), and held 1 more directorship. The companies operate in Manufacturing and Metal & Minerals.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shri Sai Cottex Private Limited U01403MH2012PTC237024 | Director | 19 Oct 2012 | 2012 | ₹8.7 Lakh (FY 2025) | Active |
| Kasa Electric Components Private Limited U31500MH1996PTC101431 | Director | 26 Jul 1996 | 1996 | ₹6 Lakh (FY 2025) | Active |
| Designated Partner | 15 Oct 2010 | 2010 | Strike Off | ||
| Adroit Remedies Private Limited U24234MH1999PTC120505 | Additional Director | 22 Oct 2007 | 1999 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Shrikisan Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Shrikisan Sharma
Ashish Shrikisan Sharma was first appointed on 26 Jul 1996 as Director at Kasa Electric Components Private Limited. The most recent appointment on record is 19 Oct 2012 at Shri Sai Cottex Private Limited.
Ashish Shrikisan Sharma held 4 earlier board appointments: Shri Sai Cottex Private Limited (Director, 19 Oct 2012 to 06 Jun 2017); Kasa Electric Components Private Limited (Director, 26 Jul 1996 to 16 Apr 2019); Ganpati Constro Projects Limited Liability Partnership (Designated Partner, from 15 Oct 2010); Adroit Remedies Private Limited (Additional Director, from 22 Oct 2007).